Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation
- 1 April 1991
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 124 (2), 204-207
- https://doi.org/10.1016/0304-3940(91)90094-a
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the ratEuropean Journal of Pharmacology, 1990
- The role of CCK, caerulein, and CCK antagonists in nociceptionPain, 1989
- Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718European Journal of Pharmacology, 1988
- Antagonism of μ-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1–13 in the rat dorsal hornNeuroscience Letters, 1987
- Opposite Effects of δ and μ Opioid Receptor Agonists on the In Vitro Release of Substance P‐Like Material from the Rat Spinal CordJournal of Neurochemistry, 1987
- Opiate Antagonistic Function of Cholecystokinin in Analgesia and Energy Balance SystemsaAnnals of the New York Academy of Sciences, 1985
- Effect of opiates on the release of cholecystokinin from in vitro hypothalamus and frontal cortex of Zucker lean (Fa/−) and obese (fa/fa) ratsBrain Research, 1985
- Potentiation of β-endorphin effects by proglumide in ratsEuropean Journal of Pharmacology, 1985
- The binding spectrum of narcotic analgesic drugs with different agonist and antagonist propertiesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982
- Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)European Journal of Pharmacology, 1981